Mainstreet Health Investments Inc. Announces Results of Voting for Directors at Annual Meeting of Shareholders
TORONTO, May 4, 2017 /CNW/ - Mainstreet Health Investments Inc. (the "Corporation") (TSX: HLP.U) announced today the results of voting at its annual meeting of shareholders held on May 4, 2017 (the "Meeting"). Each of the nominees listed in the management information circular dated March 30, 2017 was elected as a director of the Corporation at the Meeting. According to proxies received by management in advance of the Meeting, the voting results were:
Nominee |
# of Votes |
% of Votes |
# of Votes |
% of Votes |
Paul Ezekiel Turner |
7,352,836 |
99.10% |
66,980 |
.90% |
Dan Amadori |
7,415,916 |
99.95% |
3,900 |
.05% |
Rob Dickson |
7,416,716 |
99.96% |
3,100 |
.04% |
Brad Benbow |
7,352,336 |
99.09% |
67,480 |
.91% |
Shaun Hawkins |
7,416,716 |
99.96% |
3,100 |
.04% |
Richard Turner |
6,837,176 |
92.15% |
582,640 |
7.85% |
Katherine Vyse |
7,452,315 |
99.96% |
3,100 |
.04% |
In addition, the Corporation reports that the appointment of KPMG LLP, Chartered Professional Accounts, as the Corporation's auditors for the 2017 fiscal year was passed by a majority of the votes represented at the Meeting.
Details of the voting results on all matters considered at the Meeting are available in the Corporation's report of voting results, which is available under the Corporation's profile on SEDAR at www.sedar.com.
About Mainstreet Health Investments Inc.
Mainstreet Health Investments Inc. is a health care real estate company with a portfolio of high quality properties located in the United States and Canada. Our properties are operated by best-in-class health care providers primarily under long-term, triple net leases. Our mission is to create long-term shareholder value while providing an investment opportunity that matters. For more information, visit www.mainstreethealthinvestments.com.
SOURCE Mainstreet Health Investments Inc.
![](https://rt.newswire.ca/rt.gif?NewsItemId=C3150&Transmission_Id=201705041929CANADANWCANADAPR_C3150&DateId=20170504)
Investor Relations, 1-317-582-6971, [email protected]
Share this article